Last 12 months
Inside the activity.
0 purchase rows · 78 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 35 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 9 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2022 Filed Feb 2, 2022 21:16 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 5 | $610.17 | $3,050.85 |
DisclosureSEC source: 0001708138-22-000012 · edgardoc.xml · nonDerivative · entry 11 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,487 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F8 · price: Represents volume-weighted average price of sales of 5 shares of Company stock on February 1, 2022 at prices ranging from $610.02 to $610.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:16 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 36 | $609.50 | $21,942.00 |
DisclosureSEC source: 0001708138-22-000012 · edgardoc.xml · nonDerivative · entry 10 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,492 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F7 · price: Represents volume-weighted average price of sales of 36 shares of Company stock on February 1, 2022 at prices ranging from $609.00 to $609.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:16 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 1 | $608.74 | $608.74 |
DisclosureSEC source: 0001708138-22-000012 · edgardoc.xml · nonDerivative · entry 9 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,528 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:16 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 3 | $607.56 | $1,822.68 |
DisclosureSEC source: 0001708138-22-000012 · edgardoc.xml · nonDerivative · entry 8 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,529 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F6 · price: Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2022 at prices ranging from $607.46 to $607.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:16 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 20 | $606.74 | $12,134.80 |
DisclosureSEC source: 0001708138-22-000012 · edgardoc.xml · nonDerivative · entry 7 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,532 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F5 · price: Represents volume-weighted average price of sales of 20 shares of Company stock on February 1, 2022 at prices ranging from $606.07 to $606.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:16 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 7 | $605.50 | $4,238.50 |
DisclosureSEC source: 0001708138-22-000012 · edgardoc.xml · nonDerivative · entry 6 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,552 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F4 · price: Represents volume-weighted average price of sales of 7 shares of Company stock on February 1, 2022 at prices ranging from $605.19 to $605.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:16 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 1 | $604.26 | $604.26 |
DisclosureSEC source: 0001708138-22-000012 · edgardoc.xml · nonDerivative · entry 5 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,559 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:16 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 6 | $603.61 | $3,621.66 |
DisclosureSEC source: 0001708138-22-000012 · edgardoc.xml · nonDerivative · entry 4 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,560 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F3 · price: Represents volume-weighted average price of sales of 6 shares of Company stock on February 1, 2022 at prices ranging from $603.06 to $603.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:16 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 13 | $602.35 | $7,830.55 |
DisclosureSEC source: 0001708138-22-000012 · edgardoc.xml · nonDerivative · entry 3 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,566 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · price: Represents volume-weighted average price of sales of 13 shares of Company stock on February 1, 2022 at prices ranging from $602.09 to $602.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:16 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 1 | $601.79 | $601.79 |
DisclosureSEC source: 0001708138-22-000012 · edgardoc.xml · nonDerivative · entry 2 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,579 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:16 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 2 | $600.89 | $1,201.78 |
DisclosureSEC source: 0001708138-22-000012 · edgardoc.xml · nonDerivative · entry 1 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,580 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:14 UTC |
McCourt MarionEVP Commercial
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $342.93 | $0.00 |
DisclosureSEC source: 0001708138-22-000010 · edgardoc.xml · derivative · entry 4 McCourt Marion · CIK 0001663758 · EVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 1,000 shares Expires 2028-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:14 UTC |
McCourt MarionEVP Commercial
|
SaleCommon Stock | 1,000 | $607.46 | $607,460.00 |
DisclosureSEC source: 0001708138-22-000010 · edgardoc.xml · nonDerivative · entry 2 McCourt Marion · CIK 0001663758 · EVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,644 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:14 UTC |
McCourt MarionEVP Commercial
|
Exercise / conversionCommon Stock | 1,000 | $342.93 | $342,930.00 |
DisclosureSEC source: 0001708138-22-000010 · edgardoc.xml · nonDerivative · entry 1 McCourt Marion · CIK 0001663758 · EVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| January 04, 2022 Filed Mar 15, 2022 20:01 UTC |
VAGELOS P ROYDirector
|
GiftCommon Stock | 338 | $0.00 | $0.00 |
DisclosureSEC source: 0001883850-22-000020 · edgardoc.xml · nonDerivative · entry 3 VAGELOS P ROY · CIK 0001013064 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by CLAT Disclosed balance after: 141,292 Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:18 UTC |
BROWN MICHAEL SDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,707 | $0.00 Strike: $625.60 | $0.00 |
DisclosureSEC source: 0001708138-22-000005 · edgardoc.xml · derivative · entry 4 BROWN MICHAEL S · CIK 0001174475 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,707 Underlying: Common Stock · 2,707 shares Expires 2032-01-03 F3 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:18 UTC |
BROWN MICHAEL SDirector
|
GrantCommon Stock | 191 | $0.00 | $0.00 |
DisclosureSEC source: 0001708138-22-000005 · edgardoc.xml · nonDerivative · entry 1 BROWN MICHAEL S · CIK 0001174475 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,082 F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:24 UTC |
Zoghbi Huda YDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,707 | $0.00 Strike: $625.60 | $0.00 |
DisclosureSEC source: 0001883850-22-000009 · edgardoc.xml · derivative · entry 2 Zoghbi Huda Y · CIK 0001681643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,707 Underlying: Common Stock · 2,707 shares Expires 2032-01-03 F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:24 UTC |
Zoghbi Huda YDirector
|
GrantCommon Stock | 191 | $0.00 | $0.00 |
DisclosureSEC source: 0001883850-22-000009 · edgardoc.xml · nonDerivative · entry 1 Zoghbi Huda Y · CIK 0001681643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,082 F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:44 UTC |
POON CHRISTINE ADirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,707 | $0.00 Strike: $625.60 | $0.00 |
DisclosureSEC source: 0001883850-22-000012 · edgardoc.xml · derivative · entry 2 POON CHRISTINE A · CIK 0001189014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,707 Underlying: Common Stock · 2,707 shares Expires 2032-01-03 F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:44 UTC |
POON CHRISTINE ADirector
|
GrantCommon Stock | 191 | $0.00 | $0.00 |
DisclosureSEC source: 0001883850-22-000012 · edgardoc.xml · nonDerivative · entry 1 POON CHRISTINE A · CIK 0001189014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,872 F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:25 UTC |
McCourt MarionEVP Commercial
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $342.93 | $0.00 |
DisclosureSEC source: 0001883850-22-000010 · edgardoc.xml · derivative · entry 4 McCourt Marion · CIK 0001663758 · EVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 1,000 shares Expires 2028-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:25 UTC |
McCourt MarionEVP Commercial
|
SaleCommon Stock | 1,000 | $625.00 | $625,000.00 |
DisclosureSEC source: 0001883850-22-000010 · edgardoc.xml · nonDerivative · entry 2 McCourt Marion · CIK 0001663758 · EVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,644 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:25 UTC |
McCourt MarionEVP Commercial
|
Exercise / conversionCommon Stock | 1,000 | $342.93 | $342,930.00 |
DisclosureSEC source: 0001883850-22-000010 · edgardoc.xml · nonDerivative · entry 1 McCourt Marion · CIK 0001663758 · EVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:23 UTC |
Tessier-Lavigne MarcDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,707 | $0.00 Strike: $625.60 | $0.00 |
DisclosureSEC source: 0001883850-22-000008 · edgardoc.xml · derivative · entry 2 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,707 Underlying: Common Stock · 2,707 shares Expires 2032-01-03 F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:23 UTC |
Tessier-Lavigne MarcDirector
|
GrantCommon Stock | 191 | $0.00 | $0.00 |
DisclosureSEC source: 0001883850-22-000008 · edgardoc.xml · nonDerivative · entry 1 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,269 F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:23 UTC |
COLES N ANTHONYDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,707 | $0.00 Strike: $625.60 | $0.00 |
DisclosureSEC source: 0001883850-22-000007 · edgardoc.xml · derivative · entry 2 COLES N ANTHONY · CIK 0001197018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,707 Underlying: Common Stock · 2,707 shares Expires 2032-01-03 F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:23 UTC |
COLES N ANTHONYDirector
|
GrantCommon Stock | 191 | $0.00 | $0.00 |
DisclosureSEC source: 0001883850-22-000007 · edgardoc.xml · nonDerivative · entry 1 COLES N ANTHONY · CIK 0001197018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,093 F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:22 UTC |
RYAN ARTHUR FDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,707 | $0.00 Strike: $625.60 | $0.00 |
DisclosureSEC source: 0001708138-22-000008 · edgardoc.xml · derivative · entry 10 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,707 Underlying: Common Stock · 2,707 shares Expires 2032-01-03 F10 · derivative.exercise_date: On the date of the Company's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:22 UTC |
RYAN ARTHUR FDirector
|
GrantCommon Stock | 191 | $0.00 | $0.00 |
DisclosureSEC source: 0001708138-22-000008 · edgardoc.xml · nonDerivative · entry 9 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,582 F9 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:22 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 2 | $628.87 | $1,257.74 |
DisclosureSEC source: 0001708138-22-000008 · edgardoc.xml · nonDerivative · entry 8 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,391 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F8 · price: Represents volume-weighted average price of sales of 2 shares of Company stock on January 3, 2022 at prices ranging from $628.76 to $628.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2022 at each separate price. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:22 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 6 | $627.22 | $3,763.32 |
DisclosureSEC source: 0001708138-22-000008 · edgardoc.xml · nonDerivative · entry 7 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,393 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F7 · price: Represents volume-weighted average price of sales of 6 shares of Company stock on January 3, 2022 at prices ranging from $627.00 to $627.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2022 at each separate price. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:22 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 5 | $626.48 | $3,132.40 |
DisclosureSEC source: 0001708138-22-000008 · edgardoc.xml · nonDerivative · entry 6 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,399 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F6 · price: Represents volume-weighted average price of sales of 5 shares of Company stock on January 3, 2022 at prices ranging from $626.29 to $626.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2022 at each separate price. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:22 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 45 | $625.56 | $28,150.20 |
DisclosureSEC source: 0001708138-22-000008 · edgardoc.xml · nonDerivative · entry 5 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,404 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F5 · price: Represents volume-weighted average price of sales of 45 shares of Company stock on January 3, 2022 at prices ranging from $625.00 to $625.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2022 at each separate price. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:22 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 14 | $624.30 | $8,740.20 |
DisclosureSEC source: 0001708138-22-000008 · edgardoc.xml · nonDerivative · entry 4 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,449 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F4 · price: Represents volume-weighted average price of sales of 14 shares of Company stock on January 3, 2022 at prices ranging from $624.04 to $624.69. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2022 at each separate price. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:22 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 19 | $623.62 | $11,848.78 |
DisclosureSEC source: 0001708138-22-000008 · edgardoc.xml · nonDerivative · entry 3 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,463 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F3 · price: Represents volume-weighted average price of sales of 19 shares of Company stock on January 3, 2022 at prices ranging from $623.41 to $623.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2022 at each separate price. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:22 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 8 | $622.52 | $4,980.16 |
DisclosureSEC source: 0001708138-22-000008 · edgardoc.xml · nonDerivative · entry 2 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,482 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · price: Represents volume-weighted average price of sales of 8 shares of Company stock on January 3, 2022 at prices ranging from $622.32 to $622.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2022 at each separate price. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:22 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 1 | $621.98 | $621.98 |
DisclosureSEC source: 0001708138-22-000008 · edgardoc.xml · nonDerivative · entry 1 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,490 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:22 UTC |
Bassler Bonnie LDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,707 | $0.00 Strike: $625.60 | $0.00 |
DisclosureSEC source: 0001883850-22-000006 · edgardoc.xml · derivative · entry 2 Bassler Bonnie L · CIK 0001683607 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,707 Underlying: Common Stock · 2,707 shares Expires 2032-01-03 F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:22 UTC |
Bassler Bonnie LDirector
|
GrantCommon Stock | 191 | $0.00 | $0.00 |
DisclosureSEC source: 0001883850-22-000006 · edgardoc.xml · nonDerivative · entry 1 Bassler Bonnie L · CIK 0001683607 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,082 F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:21 UTC |
SING GEORGE LDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,707 | $0.00 Strike: $625.60 | $0.00 |
DisclosureSEC source: 0001708138-22-000007 · edgardoc.xml · derivative · entry 5 SING GEORGE L · CIK 0001225471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,707 Underlying: Common Stock · 2,707 shares Expires 2032-01-03 F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:21 UTC |
SING GEORGE LDirector
|
GrantCommon Stock | 191 | $0.00 | $0.00 |
DisclosureSEC source: 0001708138-22-000007 · edgardoc.xml · nonDerivative · entry 1 SING GEORGE L · CIK 0001225471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,049 F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:19 UTC |
GOLDSTEIN JOSEPH LDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,707 | $0.00 Strike: $625.60 | $0.00 |
DisclosureSEC source: 0001708138-22-000006 · edgardoc.xml · derivative · entry 2 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,707 Underlying: Common Stock · 2,707 shares Expires 2032-01-03 F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:19 UTC |
GOLDSTEIN JOSEPH LDirector
|
GrantCommon Stock | 191 | $0.00 | $0.00 |
DisclosureSEC source: 0001708138-22-000006 · edgardoc.xml · nonDerivative · entry 1 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,082 F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 21:29 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 203,204 | $0.00 Strike: $270.43 | $0.00 |
DisclosureSEC source: 0001883850-21-000034 · edgardoc.xml · derivative · entry 8 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 203,204 shares Expires 2023-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 21:29 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 239,063 | $0.00 Strike: $179.13 | $0.00 |
DisclosureSEC source: 0001883850-21-000034 · edgardoc.xml · derivative · entry 7 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 239,063 shares Expires 2022-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 21:29 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
Tax withholdingCommon Stock | 150,182 | $610.04 | $91,617,027.28 |
DisclosureSEC source: 0001883850-21-000034 · edgardoc.xml · nonDerivative · entry 4 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,019,653 Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 21:29 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
Exercise / conversionCommon Stock | 203,204 | $270.43 | $54,952,457.72 |
DisclosureSEC source: 0001883850-21-000034 · edgardoc.xml · nonDerivative · entry 3 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,169,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 21:29 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
Tax withholdingCommon Stock | 159,915 | $610.04 | $97,554,546.60 |
DisclosureSEC source: 0001883850-21-000034 · edgardoc.xml · nonDerivative · entry 2 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 966,631 Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 21:29 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
Exercise / conversionCommon Stock | 239,063 | $179.13 | $42,823,355.19 |
DisclosureSEC source: 0001883850-21-000034 · edgardoc.xml · nonDerivative · entry 1 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,126,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.